Neptune Wellness Solutions ROE 2010-2023 | NEPTF
Current and historical return on equity (ROE) values for Neptune Wellness Solutions (NEPTF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Neptune Wellness Solutions ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2023-12-31 | $-0.05B | $-0.05B | 137.66% |
| 2023-09-30 | $-0.03B | $-0.04B | 158.14% |
| 2023-06-30 | $-0.06B | $-0.04B | 800.00% |
| 2023-03-31 | $-0.06B | $-0.03B | -413.79% |
| 2022-12-31 | $-0.07B | $0.02B | -179.59% |
| 2022-09-30 | $-0.08B | $0.02B | -143.86% |
| 2022-06-30 | $-0.06B | $0.05B | -76.31% |
| 2022-03-31 | $-0.08B | $0.06B | -75.76% |
| 2021-12-31 | $-0.09B | $0.10B | -71.88% |
| 2021-09-30 | $-0.13B | $0.11B | -108.55% |
| 2021-06-30 | $-0.13B | $0.13B | -111.86% |
| 2021-03-31 | $-0.12B | $0.14B | -106.96% |
| 2020-12-31 | $-0.11B | $0.09B | -102.33% |
| 2020-09-30 | $-0.05B | $0.12B | -43.17% |
| 2020-06-30 | $-0.05B | $0.11B | -44.34% |
| 2020-03-31 | $-0.05B | $0.11B | -48.29% |
| 2019-12-31 | $-0.03B | $0.12B | -31.90% |
| 2019-09-30 | $-0.03B | $0.11B | -48.89% |
| 2019-06-30 | $-0.02B | $0.05B | -33.04% |
| 2019-03-31 | $-0.02B | $0.05B | -28.22% |
| 2018-12-31 | $0.00B | $0.06B | 0.00% |
| 2018-09-30 | $0.00B | $0.07B | 3.49% |
| 2018-06-30 | $0.00B | $0.06B | 3.77% |
| 2016-11-30 | $0.00B | $0.05B | 6.09% |
| 2016-05-31 | $-0.01B | $0.05B | -13.89% |
| 2016-03-31 | $0.00B | $0.05B | -10.81% |
| 2015-12-31 | $-0.01B | $0.05B | -23.53% |
| 2015-09-30 | $-0.01B | $0.05B | -21.05% |
| 2015-06-30 | $-0.02B | $0.06B | -33.95% |
| 2015-03-31 | $-0.02B | $0.07B | -30.56% |
| 2014-12-31 | $-0.02B | $0.07B | -21.48% |
| 2014-09-30 | $-0.02B | $0.08B | -33.95% |
| 2014-06-30 | $-0.02B | $0.09B | -24.29% |
| 2014-03-31 | $-0.02B | $0.06B | -28.17% |
| 2013-12-31 | $-0.02B | $0.05B | -28.85% |
| 2013-06-30 | $-0.02B | $0.05B | -38.55% |
| 2013-03-31 | $-0.02B | $0.06B | -43.84% |
| 2012-12-31 | $-0.02B | $0.06B | -43.87% |
| 2012-09-30 | $-0.01B | $0.03B | -15.63% |
| 2012-06-30 | $0.00B | $0.03B | -9.84% |
| 2012-03-31 | $0.00B | $0.03B | -10.62% |
| 2011-12-31 | $0.00B | $0.03B | -4.26% |
| 2011-09-30 | $0.00B | $0.03B | 5.06% |
| 2011-06-30 | $0.00B | $0.02B | 19.05% |
| 2011-03-31 | $0.00B | $0.01B | 32.65% |
| 2010-12-31 | $0.00B | $0.02B | 19.05% |
| 2010-09-30 | $0.00B | $0.01B | 23.53% |
| 2010-06-30 | $0.00B | $0.01B | 13.79% |
| 2010-03-31 | $0.00B | $0.01B | 0.00% |
| 2009-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.053B |
| Neptune Wellness Solutions Inc. is a diversified and fully integrated health and wellness company. It provides turnkey product development and supply chain solutions to business customers across several health and wellness verticals, including legal cannabis and hemp, nutraceuticals and white label consumer packaged goods. Neptune Wellness Solutions Inc. is headquartered in Laval, Quebec. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.128B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.33 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.52 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.92 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.17 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |